Publications by authors named "Naoki Shingaki"

Claim this Profile
L
Lusutrombopag Reduces the Risk of Hemoperitoneum Caused by Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma Compared with Platelet Transfusion.
Shinya Taki, Yoshiyuki Ida, Hideyuki Tamai, Shuya Maeshima, Ryo Shimizu, Naoki Shingaki

Dig Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feeding artery ablation before radiofrequency ablation for hepatocellular carcinoma may reduce critical recurrence.
Ryo Shimizu, Hideyuki Tamai, Yoshiyuki Ida, Shuya Maeshima, Naoki Shingaki

JGH Open· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of F-fluorodeoxyglucose positron emission tomography in patients with small hepatocellular carcinoma treated by radiofrequency ablation.
Yoshiyuki Ida, Hideyuki Tamai, Naoki Shingaki, Ryo Shimizu, Shuya Maeshima

Cancer Imaging· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over.
Hideyuki Tamai, Naoki Shingaki, Yoshiyuki Ida, Ryo Shimizu, Shuya Maeshima

World J Hepatol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination with portosystemic shunt occlusion and antiviral therapy improves prognosis of decompensated cirrhosis.
Hideyuki Tamai, Hiroki Minamiguchi, Yoshiyuki Ida, Naoki Shingaki, Tokuro Muroki

JGH Open· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world safety and efficacy of sofosbuvir and ledipasvir for elderly patients.
Hideyuki Tamai, Naoki Shingaki, Yoshiyuki Ida, Ryo Shimizu, Shuya Maeshima

JGH Open· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Real-World Safety and Efficacy of Daclatasvir and Asunaprevir for Elderly Patients.
Shinya Taki, Hideyuki Tamai, Yoshiyuki Ida, Naoki Shingaki, Akira Kawashima

Gut Liver· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irregular Defects in Hepatocellular Carcinomas During the Kupffer Phase of Contrast-Enhanced Ultrasonography with Perfluorobutane Microbubbles: Pathological Features and Metastatic Recurrence After Surgical Resection.
Junya Nuta, Naoki Shingaki, Yoshiyuki Ida, Ryo Shimizu, Shinya Hayami

Ultrasound Med Biol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C Virus.
Hideyuki Tamai, Yoshiyuki Ida, Akira Kawashima, Naoki Shingaki, Ryo Shimizu

Gut Liver· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Add-on Pegylated Interferon Alpha-2a Therapy in Chronic Hepatitis B Japanese Patients Treated with Entecavir.
Hideyuki Tamai, Yoshiyuki Ida, Naoki Shingaki, Ryo Shimizu, Kazuhiro Fukatsu

Hepat Res Treat· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection.
Mikitaka Iguchi, Jun Kato, Takeichi Yoshida, Yasuhide Yamamoto, Kenichiro Nakachi, Naoki Shingaki

Int J Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus.
Hideyuki Tamai, Naoki Shingaki, Yoshiyuki Mori, Kosaku Moribata, Akira Kawashima

Gut Liver· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of Contrast-Enhanced Sonography With Perfluorobutane Microbubbles for Diagnosis of Recurrent Hepatocellular Carcinoma.
Buyanjargal Shagdarsuren, Hideyuki Tamai, Naoki Shingaki, Yoshiyuki Mori, Shuya Maeshima

J Ultrasound Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypointense hepatocellular carcinomas on apparent diffusion coefficient mapping: Pathological features and metastatic recurrence after hepatectomy.
Yoshiyuki Mori, Hideyuki Tamai, Naoki Shingaki, Shinya Hayami, Masaki Ueno

Hepatol Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic features associated with development of metachronous gastric cancer in patients who underwent endoscopic resection followed by Helicobacter pylori eradication.
Kosaku Moribata, Jun Kato1 Mikitaka Iguchi, Kenichiro Nakachi, Yoshimasa Maeda, Naoki Shingaki

Dig Endosc· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma.
Ryo Shimizu, Hideyuki Tamai, Yoshiyuki Mori, Naoki Shingaki, Shuya Maeshima

Hepatol Int· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kupffer Imaging by Contrast-Enhanced Sonography With Perfluorobutane Microbubbles Is Associated With Outcomes After Radiofrequency Ablation of Hepatocellular Carcinoma.
Junya Nuta, Hideyuki Tamai, Yoshiyuki Mori, Naoki Shingaki, Shuya Maeshima

J Ultrasound Med· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Argon plasma coagulation is effective for prevention of recurrent esophageal varices after endoscopic injection sclerotherapy: Single-center case-control study.
Hisanobu Deguchi, Jun Kato, Yoshimasa Maeda, Kosaku Moribata, Naoki Shingaki

Dig Endosc· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of surgery and radiofrequency ablation on single nodular HCC ⩽5 cm: Cohort study based on serum HCC markers.
Masaki Ueno, Shinya Hayami, Yoshinobu Shigekawa, Manabu Kawai, Seiko Hirono, Naoki Shingaki

J Hepatol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Japanese apricot improves symptoms of gastrointestinal dysmotility associated with gastroesophageal reflux disease.
Takao Maekita, Jun Kato, Shotaro Enomoto, Takeichi Yoshida, Hirotoshi Utsunomiya, Naoki Shingaki

World J Gastroenterol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic effect of response to interferon therapy after laparoscopic splenectomy among patients with marked thrombocytopenia and hepatitis C virus-related cirrhosis.
Hideyuki Tamai, Yoshiyuki Mori, Naoki Shingaki, Ryo Shimizu, Jyunya Nuta

Hepatol Int· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Sustained Virological Response to Telaprevir-Based Triple Therapy Using Viral Response within 2 Weeks.
Hideyuki Tamai, Ryo Shimizu, Naoki Shingaki, Yoshiyuki Mori, Shuya Maeshima

Hepat Res Treat· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of a null response to pegylated interferon α-2b plus ribavirin in patients with high viral load genotype 1b hepatitis C.
Yuki Wada, Hideyuki Tamai, Akira Kawashima, Naoki Shingaki, Yoshiyuki Mori

Gut Liver· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography.
Kenichiro Nakachi, Hideyuki Tamai, Yoshiyuki Mori, Naoki Shingaki, Kosaku Moribata

Cancer Imaging· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serological and histological indices of hepatocellular carcinoma and tumor volume doubling time.
Naoki Shingaki, Hideyuki Tamai, Yoshiyuki Mori, Kosaku Moribata, Shotaro Enomoto

Mol Clin Oncol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis